Men get breast cancer because they have a small amount of breast tissue behind the nipple, and that tissue contains ducts that can become cancerous. Roughly 0.5% to 1% of all breast cancers occur in men, and the disease most commonly develops in the ducts located directly behind the areola. The process is driven largely by the same forces that cause breast cancer in women: hormonal exposure, genetic mutations, and cellular damage that leads to uncontrolled growth.
Why Men Have Breast Tissue at All
All embryos develop identical breast structures in early weeks of gestation, before sex hormones kick in. In girls, puberty triggers significant breast development. In boys, rising testosterone suppresses that growth, but the underlying ductal tissue never disappears. It remains as a thin layer of ducts and surrounding tissue in the chest, concentrated in the area just behind the nipple. That small amount of tissue is enough for cancer to take root.
The Role of Estrogen
Estrogen is the primary driver of male breast cancer. While men produce far less estrogen than women, the hormone is still present and active. Research published in the Journal of Clinical Oncology found that men with the highest circulating estrogen levels had roughly 2.5 times the odds of developing breast cancer compared to men with the lowest levels. The proposed explanation is straightforward: estrogen stimulates cell growth in breast tissue, and more cell division means more opportunities for DNA errors that can turn cancerous.
Anything that tips a man’s hormonal balance toward higher estrogen or lower testosterone raises risk. This imbalance can happen in several ways, and most of the major risk factors for male breast cancer trace back to this single mechanism.
Obesity and Estrogen Production
Fat tissue is an active hormone factory. Cells surrounding fat deposits contain an enzyme called aromatase, which converts circulating testosterone into estrogen. The more body fat a man carries, the more aromatase activity occurs, and the higher his estrogen levels climb. Inflammation in fatty tissue amplifies this effect further, because inflammatory signals directly boost aromatase production. This creates a feedback loop where excess weight generates both more estrogen and more inflammation, each reinforcing the other.
This is one of the most modifiable risk factors for male breast cancer. Maintaining a healthy weight reduces the amount of estrogen the body produces from fat tissue.
Klinefelter Syndrome
Men born with Klinefelter syndrome carry an extra X chromosome (XXY instead of XY). This genetic condition causes the testes to produce less testosterone than normal while also increasing estrogen levels through overproduction of aromatase. The combination creates exactly the kind of hormonal environment that promotes breast tissue growth and cancer development. Men with Klinefelter syndrome often develop gynecomastia (enlarged breast tissue), which is itself a recognized risk factor for breast cancer.
The numbers are striking. A combined analysis of Danish and British patient data found that men with Klinefelter syndrome had an 18-fold higher incidence of breast cancer compared to the general male population.
Liver Disease
The liver metabolizes and clears estrogen from the bloodstream. When liver function declines, as with cirrhosis from heavy alcohol use or hepatitis, estrogen accumulates. Men with advanced liver disease often develop gynecomastia for this reason, and their breast cancer risk rises along with their estrogen levels.
BRCA Gene Mutations
Inherited mutations in the BRCA1 and BRCA2 genes are among the strongest known risk factors. These genes normally help repair damaged DNA. When they don’t function properly, cells lose a critical safety mechanism against cancerous growth.
According to the National Cancer Institute, men with a BRCA2 mutation have a 1.8% to 7.1% chance of developing breast cancer by age 70. Men with a BRCA1 mutation face a 0.2% to 1.2% risk. For comparison, the baseline risk for men in the general population is about 0.1% by age 70. That means a BRCA2 mutation can increase a man’s risk by up to 70 times. Men with a family history of breast cancer, particularly in male relatives or multiple female relatives, may want to discuss genetic testing with their doctor.
Chest Radiation Exposure
Men who received radiation therapy to the chest earlier in life, typically for conditions like Hodgkin lymphoma during childhood or young adulthood, face elevated breast cancer risk later on. Radiation damages DNA in breast tissue cells, and those mutations can take decades to develop into cancer. This is one reason male breast cancer tends to appear later in life, even when the triggering exposure happened years earlier.
What It Looks and Feels Like
The most common sign is a painless lump or area of thickening in the chest, usually right behind or near the nipple. Because men have so little breast tissue, lumps are often easier to feel than in women, but many men don’t think to check or don’t recognize what they’re feeling. Other warning signs include:
- Skin changes on the chest, including dimpling, puckering, scaling, or discoloration
- Nipple changes such as the nipple turning inward, developing scaly skin, or changing color
- Nipple discharge, sometimes bloody
- Redness or irritation of the skin over the breast area
Because most men don’t consider breast cancer a possibility, they tend to ignore early symptoms longer than women do. This delay in recognition is a significant problem, since the cancer can spread to lymph nodes and beyond while the lump is being dismissed as a cyst or minor irritation.
How It’s Diagnosed
If you notice a lump or any of the symptoms above, diagnosis typically starts with imaging. Men can get mammograms, just like women, along with ultrasound or MRI to get a clearer picture of the tissue. If imaging reveals something suspicious, the next step is a biopsy: a needle is guided into the lump using imaging for precision, and a small sample of cells is removed for examination under a microscope.
Lab analysis also checks whether the cancer cells have hormone receptors, which tells doctors whether the cancer is fueled by estrogen or progesterone. This matters because it determines which treatments will be most effective. The cells are also tested for specific DNA changes that can guide treatment decisions.
Survival Rates by Stage
When male breast cancer is caught while still localized to the breast, the five-year survival rate is 98.7%. That number drops to 83.7% when the cancer has spread to nearby lymph nodes, and falls sharply to 25.9% when it has reached distant organs. The gap between early and late detection is enormous, which makes recognizing symptoms early genuinely lifesaving.
The challenge is that male breast cancer is rare enough that many men and even some primary care providers don’t immediately consider it. Any persistent, unexplained lump in the chest area, especially behind the nipple, warrants prompt evaluation. The diagnostic process is quick and straightforward, and the earlier cancer is found, the more treatable it is.